Accessing your medicines can be confusing. It doesn’t have to be.
PhRMA member companies are committed to helping patients make more informed health care decisions by providing more transparency about medicine costs. This, along with the development of the Medicine Assistance Tool, provides patients with the information they need to make more educated health care decisions.
Your one stop for UDENYCATM patient access and reimbursement support.
Explore this robust resource bank of curated nationally available materials to support your metastatic breast cancer patients.
Living with a serious illness can come with many challenges. Getting Genentech medicines shouldn’t be one of them. The Genentech Patient Foundation gives free Genentech medicine to people who don’t… read more //
Access 360 is a program provided by AstraZeneca to help you access and afford AstraZeneca medicines. We can work with your health care provider to identify your coverage and out-of-pocket… read more //
Boehringer Ingelheim is on a mission to improve lives around the world. We do this by developing innovative medicines and helping patients gain access to them – wherever they may… read more //
The Eisai Assistance Program is your resource for information about benefits for Eisai products and available financial assistance options. If needed, our specialists can also discuss options for financial assistance… read more //
Bristol Myers Squibb is committed to helping appropriate patients initiate and maintain access to our medications during the treatment journey. That’s why we created BMS Access Support®, which offers benefit… read more //
Our financial assistance program provides patients with the opportunity for comprehensive genomic profiling, regardless of financial status. We also offer direct support and guidance during each step of the billing… read more //
Sandoz One Source provides a variety of patient support and information including comprehensive insurance verification, prior authorization information, billing and coding information, denials/appeals information, general payer policy research, information on… read more //